Accelerating AI adoption in Bio-Pharma through collaboration

 

 

From image recognition for radiology to treatment tailoring, there is a myriad of new solutions emerging from the startup scene applying AI to the medical and pharma sector. Yet, successful collaborations between innovative businesses and large healthcare players are still rare.

 

In this white paper, INSEAD, Early Metrics and Agalio analysed new data and expert opinions to uncover potential solutions that could facilitate AI adoption in the healthcare industry. 


Download the paper to discover insights from executive directors of large pharma groups - including AstraZeneca, Novartis, Amgen, Biogen and more - as well as pioneering AI startups.